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This data article contains data related to the research article
entitled, “in vitro characterization of bone marrow stromal cells
from osteoarthritic donors” [1]. Osteoarthritis (OA) represents the
main indication for total joint arthroplasty and is one of the most
frequent degenerative joint disorders. However, the exact etiology
of OA remains unknown. Bone marrow stromal cells (BMSCs) can
be easily isolated from bone marrow aspirates and provide an
excellent source of progenitor cells. The data shows the identiﬁ-
cation of pivotal genes and pathways involved in osteoarthritis by
comparing gene expression patterns of BMSCs from osteoarthritic
versus healthy donors using an array-based approach.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Medicine
ore speciﬁc sub-
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M. Stiehler et al. / Data in Brief 8 (2016) 545–548546ow data was
acquiredAffymetrixs GeneChip Human Genome U133 Plus 2.0 Arrays (Affymetrixs,
Santa Clara, USA), Affymetrix, NetAffx™ Analysis Centerata format Analyzed
xperimental
factorsBone marrow aspirates were obtained from the pelvic compartment of
advanced-stage idiopathic hip osteoarthritic and age-matched healthy donors.
After BMSCs isolation and expansion until subconﬂuency total RNA of BMSCs at
passage 1 was analyzed.xperimental
featuresPivotal genes and pathways involved in osteoarthritis were examined by
microarray analysis.ata source
locationDresden, Germanyata accessibility Data are within this articleD
Value of the data
 Gene expression patterns of BMSCs from osteoarthritic versus healthy donors were compared to
identify pivotal genes and pathways ﬁgure out the exact etiology of OA.
 Data may serve as starting point to develop new therapies to treat OA.
 The data indicate well-characterized (clinical, radiological, cellular and subcellular data) osteoar-
thritic and healthy control donor populations.
 OA is a frequent comorbidity potentially inﬂuencing bone regeneration, therefore OA-BMSCs are of
interest in the ﬁeld of tissue engineering.1. Data
This data article provides a list of the most signiﬁcantly up and down regulated genes in BMSCs
from osteoarthritic donors compared to healthy individuals arranged by p-value (Fig. 1). The 50 most
signiﬁcantly differentially expressed genes between OA and control groups were analyzed with
respect to Gene Ontology term enrichment (Fig. 2).2. Experimental design, materials and methods
Patients recruitment and characterization as well as cell isolation and cultivation is described in
the research article entitled, “in vitro characterization of bone marrow stromal cells from osteoar-
thritic donors” by Stiehler et al., Stem Cell Research 2016 [1].
2.1. Microarray analysis
After cell expansion until subconﬂuency total RNA of MSCs at passage 1 was analyzed using
Affymetrixs GeneChip Human Genome U133 Plus 2.0 Arrays (Affymetrixs, Santa Clara, USA) by AROS
Applied Biotechnology A/S, Aarhus, Denmark. One MSC-pellet (passage 1, approx. 3–5 106 MSC) per
donor was shipped on dry ice to AROS core facility.
Raw data were processed by background correction, normalization, and robust multichip analysis
followed by statistical analysis using “R” (The Comprehensive R Archive Network, https://cran.r-
project.org 2010) and one-way ANOVA for gender-related or intergroup gene expression differences.
2.2. Gene Ontology analysis
A ranking with 690 intergroup differentially regulated genes was established using NetAffx™
Analysis Center (http://www.affymetrix.com 2010). Gene Ontology analysis was performed by DAVID
(http://david.abcc.ncifcrf.gov 2011).
Fig. 1. (A) Top 50 of the most signiﬁcantly up and down regulated genes in BMSCs from osteoarthritic donors compared to
healthy individuals arranged by p-value. (B) Difference in gene expression of the most signiﬁcantly regulated genes; value40
denote up-regulation, valueo0 denote down-regulation.
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Fig. 2. Percentaged Gene Ontology term enrichment of the 50 most signiﬁcantly differentially expressed genes from
osteoarthritic compared to healthy donors.
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